default author photo

Miwa Morikawa

Tokyo Shinagawa Hospital

Tokyo

Japan

  • Tokyo Shinagawa Hospital

SCHOLARLY PAPERS

2

DOWNLOADS

138

TOTAL CITATIONS

1

Scholarly Papers (2)

Actions:
Email selected abstracts
1.

Association of Nontuberculous Mycobacterial Infections with Myeloperoxidase-Antineutrophil Cytoplasmic Antibody-Positive Microscopic Polyangiitis: A Case Report and Literature Review

Number of pages: 22 Posted: 18 Mar 2025 Last Revised: 15 Sep 2025
Hidenori Takahashi, Riho Nakagawa, Mio Toyama-Kousaka, Yugo Satake, Hiroki Nagamatsu, Ryutaro Hirose, Naoya Toba, Shinichiro Ota, Miwa Morikawa, Kazuyoshi Ishigaki and Masaharu Shinkai
Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, Tokyo Shinagawa Hospital, RIKEN Center for Integrative Medical Sciences and Tokyo Shinagawa Hospital
Downloads 106 (659,652)

Abstract:

Loading...

Nontuberculous mycobacteria, MPO-ANCA, microscopic polyangiitis, rituximab, erythromycin, neutrophil extracellular traps

2.

Distinct Immune Cell Dynamics Correlate with the Immunogenicity and Reactogenicity of SARS-CoV-2 mRNA Vaccine

Number of pages: 71 Posted: 04 Nov 2021
Tomohiro Takano, Miwa Morikawa, Yu Adachi, Kiyomi Kabasawa, Nicolas Sax, Saya Moriayma, Lin Sun, Masanori Isogawa, Ayae Nishiyama, Taishi Onodera, Kazutaka Terahara, Keisuke Tonouchi, Masashi Nishimura, Kentaro Tomii, Kazuo Yamashita, Takayuki Matsumura, Masaharu Shinkai and Yoshimasa Takahashi
National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, KOTAI Biotechnologies, Inc., National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital, National Institute of Advanced Industrial Science and Technology (AIST) - Artificial Intelligence Research Center (AIRC), KOTAI Biotechnologies, Inc., National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development, Tokyo Shinagawa Hospital and National Institute of Infectious Diseases - Research Center for Drug and Vaccine Development
Downloads 32 (1,290,922)
Citation 1

Abstract:

Loading...

SARS-CoV-2, Vaccine, Reactogenicity, immune correlates